Pfizer Will Highlight Celebrex Safety In ’07
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm to address cardiovascular safety for the COX-2 inhibitor in a new DTC advertising campaign.
You may also be interested in...
Celebrex Ad Prompts Criticism From Consumer Group
Public Citizen urges FDA to order Pfizer to stop “dangerous” and “misleading” direct-to-consumer ad.
Celebrex Ad Prompts Criticism From Consumer Group
Public Citizen urges FDA to order Pfizer to stop “dangerous” and “misleading” direct-to-consumer ad.
Validity of Celebrex Patents Upheld In Court, Barring Generics Until 2015
ANDA filer Teva says it will appeal a federal court decision over the COX-2 inhibitor.